Diabetes drug could be new weapon against gout pain
NCT ID NCT06674109
Summary
This study is testing if a medication called empagliflozin, commonly used for diabetes, can help control gout. Researchers will give the drug or a placebo to 60 adults with gout for 12 weeks to see if it lowers uric acid levels and reduces inflammation. The goal is to gather evidence to see if this drug could become a new option for long-term gout management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT AND HYPERURICEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.